跳至主要内容
临床试验/NCT03392363
NCT03392363已完成不适用

Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds 2

ResApp Health Limited3 个研究点 分布在 1 个国家目标入组 1,470 人开始时间: 2018年1月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,470
试验地点
3
主要终点
Diagnosis of pneumonia

研究概览

简要总结

The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood acute respiratory disease, including pneumonia, bronchiolitis, asthma/reactive airways disease, croup, lower respiratory tract disease (LRTD), viral lower respiratory tract infection (vLRTI), and upper respiratory tract disease (URTD).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
29 Days 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Infant or child aged greater than 29 days up to and including their 12th birthday (infant and children pediatric subgroups as defined in Guidance for Industry and Food and Drug Administration Staff: Premarket Assessment of Pediatric Medical Devices dated March 24, 2014)
  • Presenting to the study site (an outpatient facility, an urgent care center, an Emergency Department, or inpatient ward within 24 hours of admission) with current signs or symptoms of respiratory disease including cough, wheezing, stridor, chest in-drawing/retractions, difficulty breathing, fast breathing, nasal congestion/rhinorrhea, abnormal lung sounds on exam or cyanosis/hypoxemia.
  • Onset of symptoms within past 14 days
  • Outpatient or inpatient within 24 hours of admission
  • Coughing spontaneously or able to cough voluntarily

排除标准

  • Lack of a signed consent form from parent or legal guardian
  • Lack of signed assent form for children aged 7 years or older who, in the opinion of the investigator, is able to provide assent based on their age, maturity or psychological state.
  • Need for mechanical ventilatory support ((including invasive, CPAP, or BiPAP)) or high flow nasal cannula
  • History of structural airways abnormalities, tracheobronchomalacia, or vocal cord abnormalities (e.g. laryngomalacia, tracheomalacia, or bronchomalacia)
  • Any medical contraindication to voluntary cough, including the following (only enroll if coughing spontaneously): severe respiratory distress, history of pneumothorax, eye/chest/abdominal surgery in past 3 months, hemoptysis in the past month
  • Too medically unstable to participate in study per treating clinician
  • Subject previously enrolled in SMARTCOUGH-C-2 study
  • Tracheostomy present or tube placed

结局指标

主要结局

Diagnosis of pneumonia

时间窗: 6 months

Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with (1) World Health Organization (WHO) Primary Endpoint Pneumonia (PEP) plus clinical pneumonia, (2) WHO PEP or Other Infiltrate plus clinical pneumonia, (3) Clinical pneumonia alone

Diagnosis of other childhood respiratory diseases

时间窗: 6 months

Positive percent agreement and negative percent agreement to diagnose and rule out: lower respiratory tract disease (i.e. respiratory condition occurring below the level of the larynx), viral lower respiratory tract infection, bronchiolitis, asthma/reactive airways disease, upper respiratory tract disease, and croup.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验